Angioplasty, Balloon, Coronary/mortality; Antibodies, Monoclonal/administration & dosage; Cardiovascular Agents/administration & dosage; Drug-Eluting Stents; Immunoglobulin Fab Fragments/administration & dosage; Metals; Myocardial Infarction/therapy; No-Reflow Phenomenon/therapy; Platelet Aggregation Inhibitors/administration & dosage; Sirolimus/administration & dosage; Stents; Tyrosine/analogs & derivatives; Abciximab; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary/adverse effects; Angioplasty, Balloon, Coronary/instrumentation; Coronary Angiography; Coronary Circulation; Evidence-Based Medicine; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction/diagnostic imaging; Myocardial Infarction/mortality; Myocardial Infarction/physiopathology; No-Reflow Phenomenon/diagnostic imaging; No-Reflow Phenomenon/mortality; No-Reflow Phenomenon/physiopathology; Predictive Value of Tests; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Time Factors; Tirofiban; Treatment Outcome; Tyrosine/administration & dosage